Centre for Cancer Sciences
 

Image of Mark Bishton

Mark Bishton

Clinical Associate Professor and Honorary Consultant in Haematology, Faculty of Medicine & Health Sciences

Contact

Biography

I was awarded a medical degree from the University of Liverpool in 2000 and trained as a Specialist Registrar in Haematology in the East Midlands Deanery. I obtained a PhD from the Gene regulation laboratory in the Peter McCallum Cancer Centre, Melbourne, Australia 2011. I was appointed as a Consultant Haematologist at the Nottinghamshire University Hospitals NHS Trust in 2015, and then I was appointed to my current role in 2022 as Associate Professor at the University of Nottingham and Honorary Consultant Haematologist at the Nottinghamshire University Hospitals NHS Trust.

Expertise Summary

I specialise in the clinical management of all subtypes of lymphoma and histiocytoses, have extensive experiance of all phases of clinical trials, and am a member of the NCRI low grade lymphoma and health informatics data sub-groups. I am the National Cancer Registration and Analysis Service (NCRAS) lead for Haemato-oncology.

Research Summary

I have been local principal investigator on multiple industry sponsored and investigator led clinical trials. I am is currently UK co-chief investigator for REFRACT, an NCRI investigator led clinical… read more

Recent Publications

  • WEST, JOE, STILWELL, PETER, LIU, HANHUA, BAN, LU, BYTHELL, MARY, CARD, TIM R, LANYON, PETER, NANDURI, VASANTA, RANKIN, JUDITH, BISHTON, MARK J and CROOKS, COLIN J, 2022. Temporal Trends in the Incidence of Hemophagocytic Lymphohistiocytosis: A Nationwide Cohort Study From England 2003-2018. HemaSphere. 6(11), e797
  • AL-HAKIM, ADAM, POULTER, JAMES A., MAHMOUD, DINA, ROSE, AILSA M. S., ELCOMBE, SUZANNE, LACHMANN, HELEN, CARGO, CATHERINE, DUNCAN, CHRISTOPHER J. A., BISHTON, MARK, BIGLEY, VENETIA, KHAN, ANJUM and SAVIC, SINISA, 2022. Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience BRITISH JOURNAL OF HAEMATOLOGY. 199(5), 777-781
  • LIU, HANHUA, STILLER, CHARLES A., CROOKS, COLIN J., ROUS, BRIAN, BYTHELL, MARY, BROGGIO, JOHN, RANKIN, JUDITH, NANDURI, VASANTA, LANYON, PETER, CARD, TIM R., BAN, LU, ELLISS-BROOKES, LUCY, BROUGHAN, JENNIFER M., PALEY, LIZZ, WONG, KWOK, BACON, ANDREW, BISHTON, MARK and WEST, JOE, 2022. Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: A national registry study from England, 2013-2019 BRITISH JOURNAL OF HAEMATOLOGY. 199(5), 728-738
  • NASTOUPIL, LORETTA J., MORSCHHAUSER, FRANCK, SCHOLZ, CHRISTIAN W., BISHTON, MARK, YOON, SUNG-SOO, GIRI, PRATYUSH, WEI, MICHAEL C., KNAPP, ANDREA, LI, CHI-CHUNG, BOTTOS, ALESSIA, LI, HAOCHENG, PUREV, ENKHTSETSEG and BARTLETT, NANCY L., 2022. CELESTIMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab plus lenalidomide versus rituximab plus lenalidomide in patients with relapsed or refractory follicular lymphoma who have received >= 1 line of systemic therapy. JOURNAL OF CLINICAL ONCOLOGY. 40(16),

Centre for Cancer Sciences

The University of Nottingham
Centre for Biomolecular Sciences
Nottingham, NG7 2RD


telephone: +44 (0) 115 823 1546
email: MS-CCS@nottingham.ac.uk